Daiichi Sankyo announced that the first patient has been dosed in the global phase 3 TROPION-Lung17 trial. The study is evaluating DATROWAY in patients with locally advanced or metastatic nonsquamous ...

Inside a mobile lab, Our Lady of the Lake Regional Medical Center is showcasing the robotic technology its surgeons and doctors are using to detect and treat lung cancer.

A UVA Health study finds severe viral infections can prime the lungs for cancer, but vaccination appears to reduce that risk.

Severe COVID-19 and influenza infections prime the lungs for cancer and can accelerate the disease's development, but vaccination heads off those harmful effects, new research from UVA Health's Beirne ...

Learn how severe respiratory illness leaves the lungs vulnerable to cancer, and how vaccines could prevent these vulnerabilities.

Severe COVID or flu may quietly raise lung cancer risk—but vaccines appear to stop the damage before it starts.

February 2026 coverage highlighted combination EGFR therapy guidance, chemo-free treatment options, biomarker testing and ...

Researchers at the University of Gothenburg have identified a protein linked to an increased risk of metastasis and recurrence in lung cancer. The findings are presented in a study published in the ...

In recent decades, lung cancer treatment has been transformed—new surgeries, new radiation techniques, and dramatically ...

Lung cancer poses a potential smoke screen for today’s pulmonologists. Overall, incidence rates continue to decline in the US as other cancers are on the rise, yet a growing number of patients are ...

When Jim Pantelas was diagnosed with lung cancer at 52, he felt that he had brought this disease upon himself. Having started ...

New research linked severe bouts of COVID-19 or influenza to a 24 percent increased risk of lung cancer. Learn what steps could reduce your risk. New research has linked severe COVID-19 and flu with a ...